US Patent 11643401 Crystal forms of immunomodulators
Patent 11643401 was granted and assigned to Curis (company) on May, 2023 by the United States Patent and Trademark Office.
All edits
Edits on 21 Aug, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 29 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 14 Aug, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
Shu Yu0
Edits on 10 May, 2023
Golden AI
Edits made to:
Infobox (+15 properties)
Article (+326 characters)
US Patent 11643401 Crystal forms of immunomodulators
Article
The invention relates to crystalline forms of a 3-substituted 1,2,4-oxadiazole compound, including an anhydrous crystalline form, methods of their preparation, and related pharmaceutical preparations thereof. The invention also relates to preparations suitable for pharmaceutical, veterinary, and agriculturally-relevant uses.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
116434010
Date of Patent
May 9, 2023
0Patent Application Number
173504450
Date Filed
June 17, 2021
0Patent Citations
Patent Primary Examiner
CPC Code
Find more entities like US Patent 11643401 Crystal forms of immunomodulators
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.